The broker raised its price target for the bitcoin miner to $16 from $13 while reiterating its buy rating on the stock.Markets, news, Bitcoin Mining, BenchmarkRead More

You might also be interested in reading Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine.